MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about certificate

20 Jul 2022 Evaluate

In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, Jagsonpal Pharmaceuticals forwarded a copy of the Certificate received from MCS Share Transfer Agent, the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th June, 2022.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..